Effect of statin therapy on mortality in patients with non-ischemic dilated cardiomyopathy

National Medical Journal of China

Volumn 90, Issue 28, 2010, Pages 1974-1977

  Li, Xu ^a   Liu, Xing Peng ^a   Liu, Xiao Hui ^a   Du, Xin ^a   Kang, Jun Ping ^a   Lü, Qiang ^a   Wang, Hai Yun ^a   Xu, Xia ^a   Liang, Cui ^a   Yan, Qian ^a   Lei, Tao ^a   Geng, Li Li ^a   Liu, Bai Qiu ^a   Ma, Chang Sheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cardiomyopathy, congestive; Heart failure, congestive; Mortality

Indexed keywords

ALDOSTERONE; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; CARDIOVASCULAR MORTALITY; CONGESTIVE CARDIOMYOPATHY; DIABETES MELLITUS; DRUG EFFECT; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NONISCHEMIC CARDIOMYOPATHY; RISK FACTOR; SMOKING; ADULT; AGED; FEMALE; HEART FAILURE; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; CARDIOMYOPATHY, DILATED; FEMALE; HEART FAILURE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84871406275     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.28.009     Document Type: Article

References (20)

1. Downs J R, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA, 1998, 279:1615-1622.
2. The Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet, 1994, 344:1383-1389.
3. Sacks F M, Pfeffer M A, Moye L A, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med, 1996, 335:1001-1009.
4. Kjekshus J, Pedersen T R, Olsson A G, et al. The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease. J Card Fail, 1997, 3:249-254.
5. Foody J M, Shah R, Galusha D, et al. Statins and mortality among elderly patients hospitalized with heart failure. Circulation, 2006, 113:1086-1092.
6. Go A S, Lee W Y, Yang J, et al. Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA, 2006, 296: 2105-2111.
7. Ray J G, Gong Y, Sykora K, et al. Statin use and survival outcomes in elderly patients with heart failure. Arch Intern Med, 2005, 165: 62-67.
8. Scirica B M, Morrow D A, Cannon C P, et al. Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study. J Am Coll Cardiol, 2006, 47: 2326-2331.
9. Khush K K, Waters D D, Bittner V, et al. Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study. Circulation 2007, 115:576-583.
10. de Lemos J A, Blazing M A, Wiviott S D, et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA, 2004, 292: 1307-1316.
11. Vrtovec B, Okrajsek R, Golicnik A, et al. Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure. J Card Fail, 2008, 14:140-144.
12. Sola S, Mir M Q, Lerakis S, et al. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. J Am Coll Cardiol, 2006, 47:332-337.
13. Yamada T, Node K, Mine T, et al. Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study. Am Heart J, 2007, 153 Suppl:e1051-e1058.
14. Node K, Fujita M, Kitakaze M, et al. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation, 2003, 108:839-843.
15. Wojnicz R, Wilczek K, Nowalany-Kozielska E, et al. Usefulness of atorvastatin in patients with heart failure due to Inflammatory dilated cardiomyopathy and elevated cholesterol levels. Am J Cardiol, 2006, 97:899-904.
16. Kjekshus J, Apetrei E, Barrios V, et al. Rosuvastatin in older patients with systolic heart failure. N Engl J Med, 2007, 357: 2248-2261.
17. Tavazzi L, Maggioni A P, Marchioli R, et al. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet, 2008, 372: 1231-1239.
18. Braunwald E, Bristow M R. Congestive heart failure: fifty years of prog res. Circulation, 2000, 102:14-23.
19. 2008, 6:394-396.
20. Nezasa K, Higaki K, Matsumura T, et al. Liver-specific distribution of rosuvastatin in rats: comparison with pravastatin and simvastatin. Drug Metab Dispos, 2002, 30:1158-1163.